AFM
FSTX

Anson Funds Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Anson Funds Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-185,261
Closed -$658K – 388
2022
Q1 		$658K Sell
185,261
-124,442
-40% -$460K 0.05% 217
2021
Q4 		$1.55M Buy
+309,703
New +$1.87M 0.15% 124

Anson Funds Management's FSTX Position: Q2 2022 in Review

Anson Funds Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2022, closing a stake of 185,261 shares — an estimated $658K sold.

Anson Funds Management first reported a position in FSTX in Q4 2021 and held it in 2 quarters. The position peaked at $1.55M in Q4 2021. 53 funds tracked by Wall St. Rank hold FSTX as of Q2 2022.

  • Anson Funds Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Anson Funds Management sold 185,261 F-star Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $658K.
  • Anson Funds Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Anson Funds Management's F-star Therapeutics, Inc. Common Stock position peaked at $1.55M in Q4 2021.
  • 53 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Anson Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.